Featured
India has formally approved the
emergency use of two coronavirus vaccines.
The Drugs Controller General of
India (DCGI) granted its first emergency conditional approvals Jan. 3 for a
pair of COVID-19 vaccines, including Covishield, developed abroad by Astrazeneca plc
and Oxford University and manufactured by the Pune-based S...
The Oxford University
AstraZeneca coronavirus vaccine has been approved for use in the UK.
The Oxford University/AstraZeneca vaccine has been approved
by the UK medicines regulator, opening up the possibility of rapidly scaling up
vaccination against Covid-19 within days.
The Medicines and Healthcare products Regulatory Authority
(MHRA) has approved the 2 doses vaccine for use in the UK. Because it needs
only norma...
A two-dose regimen of Pfizer vaccine conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines.
The U.S. Food and Drug
Administration issued an emergency use authorization (EUA) for the second vaccine
— this one developed by Moderna for the prevention of coronavirus disease
2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2).
Authorized Use
For the prevention of 2019
coronavir...
The basis of upcoming Pfizer and Moderna coronavirus vaccines. How it works?
It’s a two-shot vaccine, so
what happens if people miss their second shot? Is a single shot still
protective?
The Pfizer-BioNTech vaccine requires two injections, given 21 days apart,
to prime the immune system well enough to fight off the coronavirus.
Two shots are needed, and the second shot is required to...
PFIZER AND BIONTECH VACCINE TO
COMBAT COVID-19
What is in the vaccine?
the Pfizer-BioNTech vaccine is based on the virus’s genetic instructions for
building the spike protein. The technology relies on a small piece of messenger
RNA (mRNA) from the coronavirus genome. It delivers a gene that codes for the
coronavirus'...
The German company BioNTech
partnered with Pfizer to develop and test a coronavirus vaccine known as
BNT162b2. The mRNA technology, short for messenger RNA vaccines like Pfizer's
are often referred to as the vaccines of the future, since the technology is
fairly new.
·
The active ingredient is messenger RN...
As the Pfizer-BioNTech COVID-19 vaccine is being evaluated by the U.S.
Food and Drug Administration (FDA) and the Moderna vaccine is soon to
follow, here’s a look at several of the top COVID-19 vaccine candidates
and where they stand as of today.
Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 StudyVaccine
candidate was found to be more than 90% effective in preventing
COVID-19 in participants without evidence of prior SARS-CoV-2 infection
in the first interim efficacy analysisAnalysis evaluated 94 confirmed cases...
